Triamterene And Hydrochlorothiazide
Product Images NDC 61919-338

2 FDA label images from Directrx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 61919-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

304 (61919 0304 90)

304 (61919 0304 90)
Packaging label for TRIAMTERENE AND HYDROCHLTHIAZIDE 37.5/25 mg tablets by DirectRX. The box contains 90 tablets generic for MAXZIDE. It lists lot number, expiration date (1/31/23), manufacturer NDC, and packaging information including distributor details.*
FDA Label Image

Label (Triamhydro338)

Label (Triamhydro338)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE 37.5 mg/25 mg, 30 tablet package label by DirectRX. The label notes the product as a generic equivalent to Maxzide, with each tablet containing Triamterene 37.5 mg and Hydrochlorothiazide 25 mg. Packaging details include lot number 338-30, discard after 08/16, and storage instructions. The label includes cautionary advice about avoiding prolonged exposure to sunlight and keeping the medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.